Annual Accounts Receivable
N/A
December 31, 2023
Summary
- VYNE annual accounts receivable is not available.
Performance
VYNE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- VYNE quarterly accounts receivable is not available.
Performance
VYNE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
VYNE Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
VYNE Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
VYNE Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $250.00 K(+6.8%) |
| Jun 2023 | - | $234.00 K(+122.9%) |
| Mar 2023 | - | $105.00 K(-77.7%) |
| Sep 2022 | - | $471.00 K(+54.9%) |
| Jun 2022 | - | $304.00 K(-43.2%) |
| Mar 2022 | - | $535.00 K(-92.9%) |
| Dec 2021 | $7.58 M(-52.1%) | $7.58 M(-24.8%) |
| Sep 2021 | - | $10.08 M(-7.2%) |
| Jun 2021 | - | $10.87 M(+1.1%) |
| Mar 2021 | - | $10.76 M(-32.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $15.82 M(+1912.6%) | $15.82 M(+41.4%) |
| Sep 2020 | - | $11.19 M(+74.6%) |
| Jun 2020 | - | $6.41 M(-23.1%) |
| Mar 2020 | - | $8.33 M(>+9900.0%) |
| Sep 2018 | - | $0.00(-100.0%) |
| Jun 2018 | - | $93.00 K(-60.3%) |
| Mar 2018 | - | $234.00 K(-70.2%) |
| Dec 2017 | $786.00 K(>+9900.0%) | $786.00 K(+70.9%) |
| Sep 2017 | - | $460.00 K(>+9900.0%) |
| Dec 2016 | $0.00 | $0.00 |
FAQ
- What is the all time high annual accounts receivable for VYNE Therapeutics?
- What is the all time high quarterly accounts receivable for VYNE Therapeutics?
What is the all time high annual accounts receivable for VYNE Therapeutics?
VYNE Therapeutics all-time high annual accounts receivable is $15.82 M
What is the all time high quarterly accounts receivable for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly accounts receivable is $15.82 M